AlgoTx Announces First Patients Dosed in US and European Arms of Phase II Clinical Trial of ATX01 in Rare Disease Erythromelalgia
12 sept. 2023 03h00 HE
|
AlgoTX
PARIS, Sept. 12, 2023 (GLOBE NEWSWIRE) -- AlgoTherapeutix (AlgoTx), a clinical stage biotechnology company developing targeted, first-in-class therapeutics for peripheral neuropathic pain,...
Global Pain Patches Market Set to Surge, Projected to Reach $7.33 Billion by 2031
01 sept. 2023 09h39 HE
|
Research and Markets
Dublin, Sept. 01, 2023 (GLOBE NEWSWIRE) -- The "Pain Patch Market By Product Type, By Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been...
Rising Prevalence Fuels Growth: Diabetic Neuropathic Pain Market Set to Surge Through 2031
29 août 2023 06h53 HE
|
Research and Markets
Dublin, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The "Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet...
Gabapentin Market revenue to reach USD 6 Billion by 2035, says Research Nester
29 août 2023 06h00 HE
|
Research Nester
New York, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The gabapentin market size is poised to grow at a CAGR of over ~ 5 % from 2023 to 2035. The market is anticipated to garner a revenue of USD 6 billion by...
Central Nervous System Therapeutics Market to hit USD 238.8 billion by 2032, says Global Market Insights Inc.
20 août 2023 20h30 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Aug. 20, 2023 (GLOBE NEWSWIRE) -- Central Nervous System Therapeutics Market size is expected to be worth USD 238.8 billion by 2032. The growing investments in R&D...
Global Gabapentin Market Set to Reach $3.07 Billion by 2030, Driven by Rising Usage for Neuropathic Pain and Epilepsy Treatment
09 août 2023 08h08 HE
|
Research and Markets
Dublin, Aug. 09, 2023 (GLOBE NEWSWIRE) -- The "Gabapentin Market Size, Share & Trends Analysis Report By Dosage Form (Tablet, Capsule, Oral Solution), By Type (Generic, Branded), By Application,...
Surge in Chronic Disorders Fuels Expansion of Global Tapentadol Market, Projected to Hit USD 5.32 Billion by 2028
31 juil. 2023 06h08 HE
|
Research and Markets
Dublin, July 31, 2023 (GLOBE NEWSWIRE) -- The "Global Tapentadol Market (2023-2028) by Type, Therapeutic Application, End User, and Geography, Competitive Analysis, Impact of Economic Slowdown &...
Global Pain Management Device Market Analysis 2023: Industry Size, Share, Trends, Opportunity, and Forecasts, 2018-2023 & 2023-2028
31 juil. 2023 05h03 HE
|
Research and Markets
Dublin, July 31, 2023 (GLOBE NEWSWIRE) -- The "Pain Management Device Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018 - 2028 Segmented By Product, By Mode of Purchase,...
Global Gabapentin Market Report 2023: Increasing Utilization of Gabapentin in Various Conditions Fuels the Sector
02 mai 2023 11h38 HE
|
Research and Markets
Dublin, May 02, 2023 (GLOBE NEWSWIRE) -- The "Global Gabapentin Market Size, Share & Industry Trends Analysis Report by Application, Dosage Form, Distribution Channel, Regional Outlook and...
Global Neuropathic Ocular Pain Market Report 2023: Increase in Product Launches by Key Market Players Drives Growth
18 avr. 2023 10h28 HE
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "Neuropathic Ocular Pain Market, By Drug Class, By Distribution Channel, And by Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030"...